Chart-Typ:
Zeitraum:
| EQS-News: Infosys und die Formel E lancieren KI-gestütztes Rennzentrum und bringen das Fanerlebnis auf die Pole Position | EQS-News: Infosys
/ Schlagwort(e): Produkteinführung/Vereinbarung
Infosys und die Formel E lancieren KI-gestütztes Rennzentrum und bringen das Fanerlebnis auf die Pole Position... ► Artikel lesen |
| Infosys and Formula E Launch AI-Powered Race Centre, Taking Fan Experience to Pole Position | New digital platform leverages Infosys Topaz to deliver real-time insights that will redefine innovation for race day and beyondBENGALURU, India, March 20, 2026 /PRNewswire/ -- Infosys (NSE:... ► Artikel lesen |
| Ethisphere recognizes Infosys among 2026 World's Most Ethical Companies | Infosys honored for its commitment to business integrity through robust ethics, compliance, and governance programs.BENGALURU, India, March 18, 2026 /PRNewswire/ -- Infosys (NSE: INFY) (BSE:... ► Artikel lesen |
| ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data | Following multiple meetings with the FDA, ImmunityBio submitted additional information requested by the Agency to support its supplemental BLA (sBLA) for papillary... ► Artikel lesen |
| ImmunityBio, Inc.: ImmunityBio Reports 700% Year-Over-Year Revenue Growth, Expanded ANKTIVA Approvals in Lung Cancer and Global Commercial Partnerships in 33 Countries with Label Expansion Plans Globally | 2025 Sales Momentum: ANKTIVA net product revenue increased 20% quarter-over-quarter, with full-year net product revenue of $113 million, representing an approximately 700% increase year-over-year... ► Artikel lesen |
| ImmunityBio, Inc.: ImmunityBio Expands Access to ANKTIVA in EU with New Distribution Partnership and Opens Irish Subsidiary to Support European Launch |
ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countries
Dublin-based subsidiary to support ImmunityBio's distribution... ► Artikel lesen |
| Energous Reports Preliminary Financial Results for Fiscal Year 2025, Marking a Transformational Year of Growth and Platform Expansion | Energous reports preliminary revenue of approximately $5.6 million for the year ended December 31, 2025, representing more than 630% year-over-year growth and record annual revenue.For the quarter... ► Artikel lesen |
| Energous Reports Further Increase in Quarterly Revenue, Driven by Accelerating Adoption of Wireless Power Networks | Successive Revenue Growth: Reports preliminary quarterly revenue of approximately $1.3 million for the three months ended September 30, 2025 - the highest quarterly revenue since 2015 - with operational... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OFA GROUP finden Sie auf Wallstreet Online.